• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2025: $113 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

The World Anesthesia Drug Market (General, Local, Adjunctive)

$3,500.00 – $7,000.00

Clear
SKU: KLI3811533 Category: Pharmaceuticals Market Research Pages: 190
  • Description
  • Table of Contents
  • Latest reports

Description

This Kalorama Information report – The World Anesthesia Drug Market – focuses on three primary segments of anesthesia:

  • General Anesthesia
  •  Local Anesthesia
  •  Adjunctive Therapies in Anesthesia

 The report covers both currently marketed and late stage development anesthesia drugs.  For each of these segments the report contains:

  • Products on the Market
  • Products in Development
  • Market Size and Forecast
  • Market Share of Key Players
  • Issues and Trends

Revenues for each segment were generated using dollar and unit sales for each product.  Forecasted figures were generated using a combination of projected surgical procedures, patent and exclusivity expirations, pricing trends, new developments and other factors.

The report includes statistical information for surgical procedures, incidence of conditions requiring surgery, and other relevant information.  Statistical information is presented as a worldwide overview, with special emphasis on the U.S.   Product chapters in this report provide an overview, description of products on the market, description of products in development, market estimates and forecasts, and competitive analysis of leading providers.  The report also includes current issues and trends affecting the industry.

The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals. Telephone interviews and email correspondence were the primary method of gathering information. For the purpose of this study Kalorama Information conducted interviews with more than 50 key industry officials, consultants, health care providers, and government personnel.  These sources were the primary basis in gathering information specifically relating to revenue and market share data presented in this report.  Specific interviews with pharmaceutical company representatives included marketing directors, division managers, and product representatives.

There are several issues and trends that are impacting the anesthesia drug market. Many of the issues are centered on safety issues, which are probably one of the most important aspects of the administration of anesthetic agents. This industry is a mature industry so it does not have the typical competitive issues often seen in other pharmaceutical segments. However, there are some issues that concern research and development of promising areas in anesthesia.

Topics included in this section include:

      • Introduction
      • Regulation of Anesthesia Drugs
      • Dentistry and Anesthesia
      • Anesthesia and Complications in Pediatric Applications
      • Allergic Reactions in Anesthesia ( inc. Propofol Recall)
      • Anesthesia and the Benefits to Depression Patients
      • Pediatric Studies in Bipolar Disorders
      • Anesthesia and Sleep
      • Gender Differences in Anesthesia Reaction
      • Manufacturing and Supply Issues
      • Drug Shortages
      • Recreational Use of Anesthetics
      • Trends in Conscious Sedation
      • Long-term Effects of Anesthesia
      • Anesthesia and Numbing Technologies


Several hundred companies compete worldwide in the anesthesia drug market.  Companies in the market consist of large pharmaceutical companies, niche pain management and anesthesia drug manufacturers, and worldwide generic drug providers.  

All market data pertains to the world market at the manufacturers’ level.  The base year for data was 2011. Historical data was provided for the years 2007 through 2010, with forecast data provided for 2012 through 2016. Compound annual growth rates (CAGRs) are provided for the 2007-2011, 2007-2016 and 2012-2016 periods for each industry segment covered.  Competitive analysis is provided for the years 2009-2011.  The forecasted market analysis for 2012-2016 was highly influenced by the probability of approval and sales of products in late stage development, product marketing, generic competition, and demographic trends.

Table of Contents

ONE: EXECUTIVE SUMMARY

Introduction

Scope and Methodology

Size and Growth of the Market

Issues and Trends Affecting Market

Leading Competitors

TWO: INTRODUCTION

Introduction and History to Anesthesia Drugs

Types of Anesthesia

 General Anesthesia

 Local Anesthesia

 Adjunctive Therapies in Anesthesia

Routes of Administration

 Inhalation

 Mask Inhalation

 Laryngeal Mask

 Endotracheal Administration

 Controlled Respiration

 Intravenous

 Topical Application

 Transdermal/Transmucosal Application

Distribution Channels

Demographics and Statistics

Medical Procedures by Type

Complications in Anesthesia

Anesthesiology—Work Force

THREE: GENERAL ANESTHESIA   

Overview

Stages of General Anesthesia

 Induction

 Excitement

Surgical Anesthesia

Overdose

Description of Products

 Brevital

 Diprivan

 Ethrane

 Forane

 Halothane

 Ketalar

 Lusedra

 Pentothal

 Suprane

 Ultane/Sevorane

Generic Drug Impact and Availability

Research and Development

Market Size and Growth

 Total Market

 Market by Delivery Method

 Market by Geographical Region

Competitive Analysis

FOUR: LOCAL ANESTHESIA

Overview

Techniques of Administration

 Topical Application

 Transdermal/Transmucosal

 Simple Local Infiltration

 Regional Injections

 Spinal and Epidural Anesthesia

 Intrathecal Block

 Epidural, Peridural Block

Description of Products

 Amides

 Carbocaine/Isocaine/Polocaine

 Citanest

 Exparel

 Marcaine/Sensorcaine

 Naropin

 Septocaine

 Xylocaine/LidoSite/Lidoderm

 Esters

 Cocaine Hydrochloride

 Nesacaine

 Novocaine

 Pontocaine

 Combinations

 EMLA

 Pliaglis

 Synera

Generic Drug Impact and Availability

Research and Development

Market Size and Growth

 Total Market

 Market by Delivery Method

 Market by Geographical Region

Competitive Analysis

FIVE: ADJUNCTIVE THERAPIES

Overview

Description of Products

 Neuromuscular Blocking Agents

 Preanesthetic Sedation and Anesthesia Maintenance

 Precedex/dexdor

 Anesthesia Reversal Agents

Generic Drug Impact and Availability

Research and Development

 Bridion (sugammadex)

 Gantacurium

 Remimazolam (CNS 7056)

Market Size and Growth

Total Market

Market by Geographical Region

Competitive Analysis

SIX: TOTAL MARKET SIZE AND FORECAST

Total Market Size and Forecast

 Anesthesia Market by Product Type

 Anesthesia Market by Geographical Region

Competitor Analysis

SEVEN: ISSUES AND TRENDS

Introduction

Regulation of Anesthesia Drugs

Dentistry and Anesthesia

Anesthesia and Complications in Pediatric Applications

Allergic Reactions in Anesthesia

Propofol Recall

Anesthesia and the Benefits to Depression Patients

Pediatric Studies in Bipolar Disorders

Anesthesia and Sleep

Gender Differences in Anesthesia Reaction

Manufacturing and Supply Issues

Drug Shortages

Propofol

Recreational Use of Anesthetics

Trends in Conscious Sedation

Long-term Effects of Anesthesia

Anesthesia and Numbing Technologies

Sedasys

EIGHT: CORPORATE PROFILES

Introduction

Acquisitions, Alliances and Agreements

Hospira and DURECT Corporation

Hospira and Javelin Pharmaceuticals, Inc.

ZARS Pharma and Nuvo Research, Inc.

Abbott Laboratories

AstraZeneca

Baxter International

Eisai Co., Ltd.

Endo Pharmaceuticals, Inc.

Hospira, Inc.

Merck/Schering-Plough

Roche

APPENDIX: List of Companies

 

LIST OF TABLES

ONE: EXECUTIVE SUMMARY

Table 1-1: The Total World Market for Anesthesia Drugs 2007-2016

Figure 1-1: The Total Market for Anesthesia Drugs 2007-2016

TWO: INTRODUCTION

Table 2-1: World Population by Selected Geographical Region, 2010 – 2050

Figure 2-1: World Population by Selected Geographical Region, 2010–2050

Table 2-2: Procedures by Type, Average Annually 2007-2011

Figure 2-2: Procedures by Type Worldwide, Average Annually 2007-2011

Figure 2-3: Procedures by Type U.S., Average Annually 2007-2011

Table 2-3: Worldwide Anesthesia Complications

Table 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year

Figure 2-4: U.S. Physician Work Force (including Anesthesiologists) by Year

THREE: GENERAL ANESTHESIA

Table 3-1: Marketed Brands for General Anesthesia Drugs  

(Brand Name, Generic Name, and Supplier)

Table 3-2: Selected Generic Drug Manufacturers and Products for General Anesthesia

Table 3-3: Brand vs. Generic General Anesthetic Market 2007-2011

Table 3-4: The Market for General Anesthesia Drugs 2007-2016

Figure 3-1: The Market for General Anesthesia Drugs 2007-2016

Figure 3-2: The Market for General Anesthesia Drugs Market Share by Delivery Method, 2011

Table 3-5: The Market for General Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011

Figure 3-3: The Market for General Anesthesia Drugs Market Share by Geographic Region, 2011

Table 3-6: The Market for General Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011

Figure 3-4: The Market for General Anesthesia Drugs Estimated Market Share by Leading Suppliers 2011

FOUR: LOCAL ANESTHESIA

Table 4-1: Selected Marketed Local Anesthesia Drugs  (Brand Name, Generic Name and Supplier)

Table 4-2: Selected Generic Drug Manufacturers and Products for Local Anesthesia

Figure 4-1: Brand vs. Generic Local Anesthetic Market 2007-2011

Table 4-3: Local Anesthesia Drugs in Development

Table 4-4: The Market for Local Anesthesia Drugs 2007-2016

Figure 4-2: The Total Market for Local Anesthesia Drugs 2007-2016

Figure 4-3: The Market for Local Anesthesia Drugs Market Share by Delivery Method, 2011

Table 4-5: The Market for Local Anesthesia Drugs Estimated Products Sales by Geographic Region, 2011

Figure 4-4: The Market for Local Anesthesia Drugs Market Share by Geographic Region, 2011

Table 4-6: The Market for Local Anesthesia Drugs Estimated Revenues and Market Share of Leading Suppliers 2009-2011

 

Figure 4-5: The Market for Local Anesthesia Drugs Estimated Market Share by

Leading Suppliers 2011

FIVE: ADJUNCTIVE THERAPIES

Table 5-1: Selected Marketed Adjunctive Therapies in Anesthesia  (Type, Brand Name, Generic Name, and Supplier)

Table 5-2: Selected Generic Drug Manufacturers and Products for Adjunctive Therapies in Anesthesia

Figure 5-1: Brand vs. Generic Adjunctive Therapies in Anesthesia Market 2007-2011

Table 5-3: Adjunctive Therapies in Anesthesia in Development

Table 5-4: The Market for Adjunctive Therapies in Anesthesia 2007-2016

Figure 5-2: The Market for Adjunctive Therapies in Anesthesia 2007-2016

Table 5-5: The Market for Adjunctive Therapies in Anesthesia Estimated Products Sales by Geographic Region, 2011

Figure 5-3: The Market for Adjunctive Therapies in Anesthesia Market Share by Geographic Region, 2011

Table 5-6: The Market for Adjunctive Therapies in Anesthesia Estimated Revenues and Market Share of Leading Suppliers 2009-2011

Figure 5-4: The Market for Adjunctive Therapies in Anesthesia Estimated Market Share by Leading Suppliers 2011

SIX: TOTAL MARKET AND FORECAST

Table 6-1: The Total World Market for Anesthesia Drugs 2007-2016

Figure 6-1: The Total Market for Anesthesia Drugs 2007-2016

Table 6-2: Anesthesia Drug Market by Type  2007-2016

Figure 6-2: Anesthesia Drug Market by Type  2007-2016

Figure 6-3: Anesthesia Drug Market by Type  2011

Figure 6-4: Anesthesia Drug Market by Type  2016

Table 6-3: Anesthesia Drug Market Estimated Products Sales by Geographic Region, 2011

Figure 6-5: Anesthesia Drug Market Market Share by Geographic Region, 2011

Table 6-4: Leading Suppliers Anesthesia Revenues and Significant Segments of Participation, 2011

Figure 6-6: Leading Suppliers—Anesthesia Revenues, 2011

 

    Cell and Gene Therapy Market Dynamics by Disease Type: Development, Trends, and Forecasts, 4th Edition (2024-2030)
    April 11, 2025
    Cell and Gene Therapy Market Deals: Investment, M&A, and Partnerships, 2021-2025 (3rd Edition)
    February 13, 2025
    Cell and Gene Therapy Deals Analysis, 2021-2024
    June 3, 2024
    Cell Therapy and Gene Therapy Markets (Markets by Disease Type), 2023-2029
    April 30, 2024

Related products

  • Placeholder image

    Worldwide Market for Prescription Dermatological Drugs – 4th Edition, The

    $3,500.00 – $7,000.00
  • Placeholder image

    OTC Women’s Health: A Supplement to Women’s Health, 3rd Edition

    $1,496.00 – $2,992.00
  • Placeholder image

    Men’s Health: The World Market for Current and Emerging Drug Therapies

    $2,625.00 – $5,250.00
  • Placeholder image

    Market for Generic Biologics: Issues, Trends, and Market Potential, The

    $1,500.00 – $3,000.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • What Is the Size of the IVD Market in 2025? September 8, 2025
  • Tariff Uncertainty Disrupts Healthcare Operations: New Diagnostic Survey Highlights Staffing Changes, Delayed Purchases, and Supply Chain Strain  June 24, 2025
  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
The Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted...The Market for Home Care Products, 7th Edition (Wheelchairs, Oxygen Products,...
Scroll to top